baber/WOPTO huggingface dataset:
Patent NZ-596146-A (NZ)
Title: Method and system for a traffic management network
Inventor: HAUK ERIC
IPC: H04W8/20
Filed: 2010-04-02
Abstract: Disclosed is a system (100) for collecting traffic data. The system (100) includes at a stationary coordinator that has cellular communications circuitry (390) connected to a first processor (310) and first networking communications circuitry (380) connected to the first processor (310). A plurality of stationary traffic data collection devices are positioned along a portion of a road and each contain second networking communications circuitry connected to a second processor. The stationary coordinator device and the stationary traffic data collection device form a network via the first networking communications circuitry (380) and the second networking communications circuitry. Each stationary traffic data collection device also includes device detection circuitry connected to the second processor configured to detect device identifiers of devices contained within vehicles traveling on the road. The second processor is configured to control transmission of the detected device identifiers to one of the stationary coordinator devices via the second networking communications circuitry. A central processing station is linked to the stationary coordinator device via the cellular communications circuitry (390) and receives a device identifier of a device from two or more stationary traffic data collection devices via one or more of stationary coordinator device. The central processing station also includes a third processor configured to calculate a speed of the device on the road, a directionality of the device on the road, and a travel time of the device on the road based upon the received device identifiers from the two or more stationary traffic data collection devices and a predetermined distance between the two or more stationary traffic data collection devices.
Patent NZ-597957-A (NZ)
Title: Otamixaban for treatment of elderly and renal impaired non-st elevation myocardial infarction patients
Inventor: STECHL JENS
IPC: A61K31/4418
Filed: 2010-07-22
Abstract: 597957 Disclosed is the use of (2R,3R)-2-(3-carbamimidoyl-benzyl)-3-[4-(1-oxy-pyridin-4-yl) benzoylamino]-butyric acid methyl ester (otamixabin) or a pharmaceutically acceptable salt thereof, for the manufacture of a medicament for the treatment of non-STelevation myocardial infarction said treatment comprising administering (2R,3R)-2-(3-carbamimidoyl-benzyl)-3-[4-(1-oxypyridin-4-yl)benzoylamino]butyric acid methyl ester or a pharmaceutically acceptable salt thereof to a human patient, who is older than 65; more preferably over 75. Also disclosed is the use of (2R,3R)-2-(3-carbamimidoyl-benzyl)-3-[4-(1-oxy-pyridin-4-yl)Benzoylamino]-butyric acid methyl ester or a pharmaceutically acceptable salt thereof, for the manufacture of a medicament for the treatment of non-ST elevation myocardial infarction said treatment comprising administering (2R,3R)-2-(3-carbamimidoyl-benzyl)-3-[4-(1-oxypyridin-4-yl) benzoylamino]butyric acid methyl ester or a pharmaceutically acceptable salt thereof to a human patient, who shows renal insufficiency; more particularly they show renal insufficiency and a creatinine (creatinin) clearance from 50 millilitre per min to 80 millilitre per min.
Patent NZ-598107-A (NZ)
Title: Herbicidal composition comprising a combination of pyroxasulfone and a second herbicide compound
Inventor: YAMAJI YOSHIHIRO
IPC: A01N33/18
Filed: 2007-12-20
Abstract: Disclosed is a herbicidal composition comprising the following Component A, and the following Component B as active ingredients wherein Component A is 3-[(5-difluoromethoxy-1-methyl-3-trifluoromethylpyrazol-4-yl)methylsulfonyl]-4,5-dihydro-5,5-dimethylisoxazole (pyroxasulfone) or a salt thereof; and Component B: propoxycarbazone-sodium.The herbicidal composition may further comprise Component C selected from the group consisting of atrazine, simazine, cyanazine, isoxaflutole, mesotrione, flumetsulam, imazapyr, dicamba, clopyralid, prosulfuron, halosulfuron-methyl, rimsulfuron, carfentrazone-ethyl, metribuzin, thifensulfuron-methyl, nicosulfuron, primisulfuron, cloransulam-methyl, glufosinate, glyphosate, sulfosate, pendimethalin, linuron, prometryne, diflufenican, flumioxazin, metolachlor, their salts and analogues; and Component D selected from the group consisting of cloquintocet-mexyl, fenchlorazole, fenchlorazole-ethyl, mefenpyr, mefenpyr-diethyl, isoxadifen, isoxadifen-ethyl, furilazole, benoxacor, dichlormid, M0N4660, oxabetrinil, cyometrinil, fenclorim, cyprosulfamide, naphthalic anhydride, flurazole, their salts and analogues.
Patent NZ-600235-A (NZ)
Title: Methods and compositions for the assessment of drug response
Inventor: GLADDING PATRICK
IPC: A61P37/00
Filed: 2009-01-23
Abstract: Disclosed are methods for predicting or determining a subject's response to an antiplatelet agent, and methods for determining a subject's suitability to a treatment regime or intervention for a disease associated with platelet aggregation, using analysis of genetic polymorphisms. The present invention also relates to the use of genetic polymorphisms in assessing a subject's response to an antiplatelet agent. Nucleotide probes and primers, kits, and microarrays suitable for such assessment are also provided.
Patent NZ-600926-A (NZ)
Title: Nitrogen-containing heterocyclic compound and agricultural/horticultural germicide
Inventor: SHIBAYAMA KOTARO
IPC: A01N43/42
Filed: 2010-12-28
Abstract: 600926 Provided are a novel nitrogen-containing heterocyclic compound represented by formula (II), and a salt or N-oxide compound thereof. Also provided is an agricultural/horticultural germicide that contains at least one of the above as an active ingredient. In formula (I), R represents the group represented by CR1R2R3 or a cyano group. R1 through R3 each independently represent a hydrogen atom, an unsubstituted or substituted C1-8 alkyl group, an unsubstituted or substituted hydroxyl group, or the like. R4 or R5 represents a halogen group or the like. Y or Z represents a carbon atom or the like, and A or D represents a benzene ring or the like. X represents an oxygen atom. Compounds of the disclosure include: 2-[2-fluoro-6-(8-fluoroquinolin-3-yloxy)-phenyl]-3,3-dimethyl-butan-2-ol, 2-[2-fluoro-6-(8-fluoroquinolin-3-yloxy)-phenyl]-propan-2-ol, 2-[2-fluoro-6-(8-fluoro-2-methylquinolin-3-yloxy)-phenyl]- propan-2-ol, and 2-[2-fluoro-6-(7,8-difluoro-2-methylquinolin-3-yloxy)-phenyl]-propan-2-ol.
Patent NZ-601131-A (NZ)
Title: Sigma ligands for use in the prevention and/or treatment of postoperative pain
Inventor: VELA HERNANDEZ JOSE MIGUEL
IPC: A61K31/415
Filed: 2011-02-04
Abstract: The disclosure refers to the use of a sigma ligand of formula (I) to prevent and/or treat acute and chronic pain developed as a consequence of surgery, especially superficial and/or deep pain secondary to surgical tissue injury, and peripheral neuropathic pain, neuralgia, allodynia, causalgia, hyperalgesia, hyperesthesia, hyperpathia, neuritis or neuropathy secondary to surgical procedure. The compound: 4-{ 2-[5-methyl-1-(naphthalen-2-yl)-1H-pyrazol-3-yloxy]ethyl} morpholine is the preferred sigma ligand.
Patent NZ-606383-A (NZ)
Title: Methods of treating pulmonary disorders with liposomal amikacin formulations
Inventor: GUPTA RENU
IPC: A61K9/127
Filed: 2009-10-13
Abstract: Disclosed is the use of an effective amount of liposomal amikacin in the preparation of a medicament for the treatment of a pulmonary disorder in a patient, wherein the medicament comprises amikacin and a lipid component comprising a phospholipid and a sterol, and the medicament is for administration to the patient via inhalation for at least two treatment cycles, wherein the treatment cycle comprises an administration period of the medicament of 15 to 75 days, followed by an off period of 15 to 75 days ; and the effective dose of the medicament comprises 100 to 2500 mg of amikacin daily during the administration period , and wherein the medicament is for administration to the patient by nebulisation.
Patent NZ-606466-A (NZ)
Title: Peptide radiotracer compositions
Inventor: RAJIV BHALLA
IPC: A61K51/08
Filed: 2011-08-11
Abstract: The present invention relates to imaging agent compositions comprising radiolabelled c-Met binding peptides suitable for positron emission tomography (PET) imaging in vivo. The c-Met binding peptides are labelled with the radioisotope F. Also disclosed are pharmaceutical compositions, methods of preparation of the agents and compositions, plus methods of in vivo imaging using the compositions, especially for use in the management of cancer.
Patent NZ-607794-A (NZ)
Title: N-acylsulfonamide apoptosis promoters
Inventor: DIEBOLD ROBERT BRUCE
IPC: C07D211/22
Filed: 2011-08-05
Abstract: Disclosed are phenylsulfonylbenzamide substituted piperidine compounds of Formula (I): and to their salts, pharmaceutical compositions, methods of use, and methods for their preparation. These compounds inhibit Bcl-2 and/or Bcl-X activities and may be used for the treatment of cancer. An example of compounds of formula (I) are: 4-(4-((R)-(2-aminoacetamido)(4’-chlorobiphenyl-2-yl)methyl)piperidin-1-yl)-N-(4-((R)-4-morpholino-1-(phenylthio)butan-2-ylamino)-3-(trifluoromethylsulfonyl)phenylsulfonyl)benzamide hydrochloride salt.
Patent NZ-609149-A (NZ)
Title: Improvements to sliding door systems
Inventor: LEWIS WARREN PAUL
IPC: E06B3/00
Filed: 2011-12-15
Abstract: A sliding door track assembly (20) is disclosed. The track assembly includes a sliding door panel (22) and a floor channel assembly (34). The floor channel assembly comprises an upward facing channel section (38) and a central rail section (40) of a width so as to fit inside the upward facing channel section with a minimum gap (42) just sufficient to accommodate the lower edges (32) of a downward facing channel section (26) of the sliding door panel, and with an upper surface (44) that is substantially flush with a floor (58) at a doorway, and formed with a rail section (48) protruding upward at the centre thereof. When the sliding door panel is slid open, the appearance of the sliding door track assembly is not marred by a gaping open channel, but appears substantially flush with the floor. Furthermore, this will present less of a hindrance to travel of wheelchairs or wheeled equipment. Wool pile strips (52) may also fill the gap that is left when the lower edge of the sliding door panel is slid open.
Patent NZ-625863-A (NZ)
Title: Methods for treatment and prevention of opioid induced constipation using oral compositions of methylnaltrexone
Inventor: BORTEY ENOCH
IPC: A61K31/485
Filed: 2012-12-19
Abstract: Disclosed is the use of a pharmaceutical composition comprising methylnaltrexone of formula I, or a salt thereof, in the preparation of a medicament, wherein the medicament is formulated for oral administration once-daily in the morning for treatment of opioid induced constipation in a subject, wherein the pharmaceutical composition comprises 150 mg, 300 mg, or 450 mg of methylnaltrexone, or a salt thereof, and dodecyl sulphate, or a salt thereof; wherein the subject has discontinued alternative laxative therapy.
Patent NZ-707825-A (NZ)
Title: Novel benzimidazole derivatives as ep4 antagonists
Inventor: ZORN LUDWIG
IPC: C07D403/04
Filed: 2013-12-03
Abstract: The present invention relates to novel benzimidazole derivatives of the general formula (I), processes for their preparation and their use for the production of pharmaceutical compositions for the treatment of diseases and indications that are connected with the receptor EP4.
Patent NZ-710626-A (NZ)
Title: Pcsk9 vaccine
Inventor: CHAMPION BRIAN ROBERT
IPC: C12N9/64
Filed: 2010-08-23
Abstract: Discloses a composition comprising a first immunogen and a second immunogen, wherein each of the first and second immunogens comprises at least one antigenic proprotein convertase subtilisin-kexin type 9 (PCSK9) peptide linked to an immunogenic carrier, wherein the antigenic PCSK9 peptide of the first immunogen consists of an amino acid sequence selected from the group consisting of SEQ ID NOs: 182-188, 317, 401, 402, and 403, and wherein the antigenic PCSK9 peptide of the second immunogen consists of an amino acid sequence selected from the group consisting of SEQ ID Nos: 46-101, 314, 318, and 319, wherein the sequences are as defined in the complete specification.
Patent NZ-718864-A (NZ)
Title: Method of preparing a photochromic optical article using an organic solvent pretreatment and photochromic coating
Inventor: KOENIG JERRY L II
IPC: C08J7/046
Filed: 2014-10-03
Abstract: A method of preparing a photochromic optical article is provided, which includes: (i) applying a first organic solvent to a surface of an optical substrate, thereby forming an organic solvent wetted surface on the optical substrate; and (ii) applying a curable photochromic coating composition over the organic solvent wetted surface of said optical substrate, thereby forming a curable photochromic coating layer over the surface of the optical substrate. The curable photochromic coating composition includes a second organic solvent, and the first and second organic solvents are miscible with each other. With some embodiments, the first and second organic solvents are the same.
Patent NZ-720894-A (NZ)
Title: Floor board assembly
Inventor: HUANG HUANWEN
IPC: E04F15/10
Filed: 2011-06-01
Abstract: Disclosed is an interlocking board assembly (201), useful for flooring, wall or ceiling boards. It includes a structural layer comprising an outer frame with latch tongues or catches (205), designed to allow interlocking with an adjacent board of similar construction, and a filler board within the frame. A decorative layer (203) is added on top of the structural layer. The tongues are shaped to have a locking surface (219), which engages with the groove (206) of an adjacent board, the latch tongues having a bevelled nose surface and the frame having a bevelled surface. The bevelled surfaces of corresponding tongues and frames of similar boards interacting to allow the boards to be snap fit together by sliding the boards in a common plane, i.e. when the boards are adjacent and horizontal.
Patent NZ-721952-A (NZ)
Title: Delayed release compositions of linaclotide
Inventor: FRETZEN ANGELIKA
IPC: A61K9/48
Filed: 2014-12-11
Abstract: The present invention relates to delayed release pharmaceutical compositions comprising linaclotide or pharmaceutically acceptable salts thereof, as well as to various methods and processes for the preparation and use of the compositions.
Patent NZ-722042-A (NZ)
Title: Antibody molecules to tim-3 and uses thereof
Inventor: FREEMAN GORDON
IPC: C07K16/28
Filed: 2015-01-30
Abstract: Antibody molecules that specifically bind to TIM-3 are disclosed. The anti-TIM-3 antibody molecules can be used to treat, prevent and/or diagnose immune, cancerous, or infectious conditions and/or disorders.
Patent NZ-724242-A (NZ)
Title: Cry1d for controlling corn earworm
Inventor: NARVA KENNETH E
IPC: C12N15/32
Filed: 2015-03-20
Abstract: The subject invention relates to the finding that Cry1Da is active against corn earworm (CEW), Helicoverpa zea (Boddie). Methods for using Cry1Da in transgenic plants to prevent serious crop damage are described. Leaf and silk bioassays using transgenic maize expressing full length, core toxin region or chimeric Cry1Da demonstrated good insect protection against CEW larvae damage.
Patent NZ-724518-A (NZ)
Title: Wearable 3d augmented reality display
Inventor: JAVIDI BAHRAM
IPC: G02B27/01
Filed: 2015-03-05
Abstract: Some previously proposed 3D augmented reality displays offer limited ability to effectively augment the real-world view in many applications. Disclosed here in is a 3D augmented reality display. The 3D augmented reality display comprises a microdisplay, display optics and an eyepiece. The microdisplay provides a virtual 3D image for display to a user, which is configured to provide a set of elemental images each having information of a different perspective of the 3D scene. The display optics are configured to receive optical radiation from the microdisplay and configured to create a 3D lightfield from the received radiation. The eyepiece is in optical communication with the display optics configured to receive the 3D lightfield from the display optics and deliver the received radiation to an exit pupil of the augmented reality display. The elemental images provide a spatially-incoherent object and conical ray bundles emitted by pixels in the elemental images intersect and integrally create the perception of a 3D scene in which objects appear to be located along a surface (AOB) having a depth range at a reference plane to provide the appearance to emit light and occupy the 3D space.
Patent NZ-729029-A (NZ)
Title: Log scanning system
Inventor: ALWESH NAWAR SAMI
IPC: G06F17/00
Filed: 2015-08-13
Abstract: A log scanning system and method for scanning a log load. Each individual log in the log load may have an ID element with a unique log ID data on at least one log end face. The system has a handheld scanner unit for free-form scanning by an operator over a load end face of the log load. The scanner unit has a depth sensor configured to capture a series of depth images of the load end face and a texture sensor configured to capture a series of texture images of the load end face during the load end face scan. The system also has a data processor(s) that receives and processes the depth and texture images captured from the scan. The processor(s) are configured to fuse the depth images or depth and texture images into a data model of the load end face, determine log end boundaries of the individual logs visible in the load end face by processing the data model, process the texture images to identify and decode any ID elements visible in the scan to extract individual log ID data, and generate output data representing the log load based on the determined log end boundaries and extracted log ID data.
Patent NZ-744874-A (NZ)
Title: Narrowband wireless communications cell search
Inventor: CHEN WANSHI
IPC: H04W4/70
Filed: 2017-01-06
Abstract: Methods, systems, and devices for wireless communication are described. A base station may broadcast a synchronization signal using a narrowband portion of a bandwidth of a cell. The synchronization signal may include a sequence repeated over several symbol periods using a cover code to support power-efficient cell acquisition. A user equipment (UE) receiving the synchronization signal may determine frequency and timing information for a cell by performing a weighted combination and accumulation of low complexity autocorrelation and cross-correlation procedures on the synchronization signal. The reduced complexity correlation procedures may be enabled based on the use of the cover code and a base sequence. In some cases, the cross-correlation may be performed at multiple sampling rates. The use of the cover code within the synchronization signal may also support correlation procedures that use recursive or repeated updates, which may allow for further reduced computational complexity relative to other cell search procedures.
Patent NZ-761924-A (NZ)
Title: Persistent writes for non-volatile memory
Inventor: RAMANUJAN RAJ
IPC: G06F12/02
Filed: 2018-08-14
Abstract: Systems and methods for persistent operations include a host and a memory system. The memory system, upon receiving a Persistent Write command and associated write data from the host, performs a Persistent Write of the write data to a non-volatile memory in the memory system based on the Persistent Write command. The memory system may also a receive a write identification (WID) associated with the Persistent Write command from the host and provide, upon successful completion of the Persistent Write, a Persistent Write completion indication along with the associated WID to the host.
Patent NZ-777503-A (NZ)
Title: Method and apparatus of interpolation filtering for predictive coding
Inventor: CHEN JIANLE
IPC: H04N19/117
Filed: 2019-12-20
Abstract: The present disclosure relates to intra- or inter-prediction for video encoding and decoding. For that purpose, an apparatus and methods obtain a reference sample and a subpixel offset value. A subpixel 4-tap interpolation filter is used to filter the reference sample to obtain a predicted sample value. The filter coefficients c0, c1, c2, and c3 of the subpixel 4-tap interpolation filter satisfy formula (I) with p being a fractional part of the value of subpixel offset.
Patent PT-107432-A (PT)
Title: Ração inerte para a espécie de camarão ornamental hymenocera picta e respetivo método de preparação
Inventor: PEDROSA RUI FILIPE PINTO
IPC: A23K1/18
Filed: 2014-01-30
Abstract: A PRESENTE INVENÇÃO DIZ RESPEITO A UMA RAÇÃO INERTE PARA A ESPÉCIE DE CAMARÃO ORNAMENTAL HYMENOCERA PICTA, COM ESTRELA DO MAR LIOFILIZADA OU SEUS DERIVADOS. NO MEIO NATURAL, ESTE CAMARÃO TEM UMA DIETA BASEADA APENAS EM ESTRELAS-DO-MAR VIVAS DE VÁRIAS ESPÉCIES, O QUE IMPEDE QUE ESTA ESPÉCIE SEJA INTRODUZIDA NO MERCADO ORNAMENTAL DEVIDO À FALTA DE UMA DIETA COMERCIAL. A RAÇÃO É CONSTITUÍDA POR NUTRIENTES RICOS E DEVIDAMENTE BALANCEADOS, QUE PROMOVEM O CRESCIMENTO E A MANUTENÇÃO DESTA ESPÉCIE NUM AQUÁRIO MARINHO. POSSUINDO CARACTERÍSTICAS SENSORIAIS QUE PROMOVEM O INTERESSE DOS CAMARÕES DESTA ESPÉCIE NO ALIMENTO INERTE, PODE CONTER VARIADAS ESPÉCIES, DANDO-SE PREFERÊNCIA ÀS ESPÉCIES COSCINASTERIAS TENUISPINA, MARTHASTERIAS GLACIALIS E ASTERINA GIBBOSA E PERMITE AOS AQUARIOFILIAS ALIMENTAR OS SEUS CAMARÕES DE UMA FORMA MAIS CÓMODA E SEM PREOCUPAÇÕES, COM UM CUSTO SIMILAR AOS ALIMENTOS TRADICIONAIS NA ÁREA DA AQUARIOFILIA.
Patent PT-116938-A (PT)
Title: Sistema e método para controlo dinâmico de lugares de estacionamento de veículos, e seus usos
Inventor: JOAQUIM MIGUEL GONÇALVES MACEDO
IPC: H04W4/021
Filed: 2020-12-14
Abstract: SISTEMA PARA CONTROLO DINÂMICO DE LUGARES DE ESTACIONAMENTO PARA UM PARQUE OU ZONA DE ESTACIONAMENTO QUE COMPREENDE: UM CONTROLADOR PRIMÁRIO PARA CONTROLAR A ENTRADA E A SAÍDA DE UM VEÍCULO NO PARQUE OU ZONA DE ESTACIONAMENTO; UM CONTROLADOR SECUNDÁRIO PARA IDENTIFICAR A CHEGADA E A PARTIDA DO UTILIZADOR NUM LOCAL PRÉ-DETERMINADO; EM QUE O CONTROLADOR SECUNDÁRIO COMPREENDE UM PROCESSADOR ELETRÓNICO DE DADOS CONFIGURADO PARA: REGISTAR O MOMENTO DE ENTRADA E SAÍDA DO UTILIZADOR NO LOCAL PRÉ-DETERMINADO; E ENVIAR UM REGISTO DE DADOS PARA O CONTROLADOR PRIMÁRIO COM O MOMENTO DE ENTRADA E SAÍDA DO UTILIZADOR DO LOCAL PRÉ-DETERMINADO; EM QUE O CONTROLADOR PRIMÁRIO COMPREENDE UM PROCESSADOR ELETRÓNICO DE DADOS CONFIGURADO PARA DETERMINAR, PARA CONTROLO DINÂMICO DE LUGARES DE ESTACIONAMENTO, UMA RESERVA DO PARQUE DE ESTACIONAMENTO ENTRE O MOMENTO DE ENTRADA DO UTILIZADOR NO LOCAL PRÉ-DETERMINADO E O MOMENTO DE SAÍDA DO UTILIZADOR NO LOCAL PRÉ-DETERMINADO.
Patent RO-86081-A (RO)
Inventor: LENNART FLORVALL G
IPC: C07D207/09
Filed: 1982-03-10
Abstract: Novel therapeutically active compounds of the formula   <IMAGE> I wherein R1 and R2 are the same or different and each represents a hydrogen atom, a halogen atom, a cyano group, a lower alkyl group or an acyl group, R3 is a lower alkyl group; an alkenyl group; or a benzyl group optionally substituted with fluorine, chlorine, bromine, trifluoromethyl, lower alkyl or lower alkoxy, A1 and A2 are the same or different and each represents a hydrogen atom, a lower alkyl group, an acyl group, an alkoxycarbonyl group or a dialkylcarbamyl group, provided that when A1 and A2 are the same lower alkyl group and R3 is ethyl, R1 or R2 or both are selected among cyano, lower alkyl and acyl; or a physiologically acceptable salt or optical isomers thereof, methods for their preparation, pharmaceutical preparations containing the compounds and methods for their therapeutical use.